Will allow to detect whether or not an early stage oral tumor has nodal metastasis, This will help onco-surgeon to decide whether not to de aggresive surgery, Approxomate number of early stage oral cancer pateint would be 75,000/year
, Projeted market value would be 150cr/year(assuming an asay cost of Rs. 20,000/-)